Biotech Innovator Targets Obesity Treatments Metsera, a biotech startup based in New York, is poised to make a significant entrance into the public markets with its upcoming IPO. The company…
**Oncolytics Biotech Inc. (TSE:ONC)** has been making headlines after its shares surged past the significant threshold of its two hundred-day moving average. During Friday's trading session, the stock peaked at…
GRAIL, a biotechnology firm, is rapidly gaining attention in the healthcare sector. Recently, its stock surged by an impressive 58% since late October, positioning it within the spotlight of investors…
In a shocking turn of events, Editas Medicine has announced a staggering 65% reduction in its workforce. This decision, impacting approximately 180 employees, comes as the biotech company decides to…
Dimension Ventures is making headlines as it embarks on an ambitious journey, setting out to raise $500 million for its second fund in under two years. This initiative is focused…
### Charles River Laboratories Launches Innovative Incubator Program Charles River Laboratories is revolutionizing the biotech landscape with the introduction of its latest incubator initiative. This program aims to support startups…
As interest rates decrease, certain tech sectors, particularly biotech, are gaining attention as promising investment options. While artificial intelligence has significantly boosted technology stocks in recent years, concerns are emerging…
Kane Biotech has delivered impressive financial results, showcasing a promising turnaround. With revenue reaching CA$1.28 million, the company experienced a substantial increase of 79% over the previous quarter. This surge…
In the competitive realm of biotechnology, **BridgeBio Pharma, Inc.** has emerged victorious with a significant regulatory approval. The company successfully secured FDA approval for its groundbreaking cardiovascular medication, acoramidis, known…
As President-elect Donald Trump announces his pick for FDA commissioner, the decision is drawing attention and sparking conversations across the biopharmaceutical sector. Industry executives and former FDA staff are closely…